Targeting STAT3 Enzyme for Cancer Treatment

被引：0
|
作者：
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构：
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2024年 / 24卷 / 13期
关键词：
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I：
10.2174/0113895575254012231024062619
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码：1252 / 1261
页数：10
相关论文
共 50 条
  • [21] Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
    Huang, W.
    Dong, Z.
    Chen, Y.
    Wang, F.
    Wang, C. J.
    Peng, H.
    He, Y.
    Hangoc, G.
    Pollok, K.
    Sandusky, G.
    Fu, X-Y
    Broxmeyer, H. E.
    Zhang, Z-Y
    Liu, J-Y
    Zhang, J-T
    ONCOGENE, 2016, 35 (06) : 783 - 792
  • [22] Targeting STAT3: A crucial modulator of sepsis
    Lei, Wangrui
    Liu, Dianxiao
    Sun, Meng
    Lu, Chenxi
    Yang, Wenwen
    Wang, Changyu
    Cheng, Ye
    Zhang, Meng
    Shen, Mingzhi
    Yang, Zhi
    Chen, Yin
    Deng, Chao
    Yang, Yang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (11) : 7814 - 7831
  • [23] Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
    Walker, Sarah R.
    Nelson, Erik A.
    Zou, Lihua
    Chaudhury, Mousumi
    Signoretti, Sabina
    Richardson, Andrea
    Frank, David A.
    MOLECULAR CANCER RESEARCH, 2009, 7 (06) : 966 - 976
  • [24] Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer
    Bharadwaj, Uddalak
    Kasembeli, Moses M.
    Eckols, T. Kris
    Kolosov, Mikhail
    Lang, Paul
    Christensen, Kurt
    Edwards, Dean P.
    Tweardy, David J.
    CANCERS, 2014, 6 (04): : 2012 - 2034
  • [25] Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells
    Jing, N
    Li, YD
    Xu, XJ
    Sha, W
    Li, P
    Feng, LL
    Tweardy, DJ
    DNA AND CELL BIOLOGY, 2003, 22 (11) : 685 - 696
  • [26] STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription
    Sun, Xinlin
    Wang, Jihui
    Huang, Min
    Chen, Taoliang
    Chen, Jiansheng
    Zhang, Fabing
    Zeng, Huijun
    Xu, Zhimin
    Ke, Yiquan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (11) : 5629 - 5638
  • [27] The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase
    Heppler, Lisa N.
    Attarha, Sanaz
    Persaud, Rosanne
    Brown, Jennifer, I
    Wang, Peng
    Petrova, Boryana
    Tosic, Isidora
    Burton, Foster B.
    Flamand, Yael
    Walker, Sarah R.
    Yeh, Jennifer E.
    Zubarev, Roman A.
    Gaetani, Massimiliano
    Kanarek, Naama
    Page, Brent D. G.
    Frank, David A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (02)
  • [28] Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
    Zheng, Jie
    de Veerdonk, Frank L. van
    Crossland, Katherine L.
    Smeekens, Sanne P.
    Chan, Chun M.
    Al Shehri, Tariq
    Abinun, Mario
    Gennery, Andrew R.
    Mann, Jelena
    Lendrem, Dennis W.
    Netea, Mihai G.
    Rowan, Andrew D.
    Lilic, Desa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (10) : 2834 - 2846
  • [29] MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
    Fan, Zhongyi
    Cui, Hanzhi
    Xu, Xiaojie
    Lin, Zhi
    Zhang, Xuelin
    Kang, Lei
    Han, Baiyu
    Meng, Jing
    Yan, Zhifeng
    Yan, Xiang
    Jiao, Shunchang
    ONCOTARGET, 2015, 6 (28) : 25266 - 25280
  • [30] MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3
    Qi, M-M
    Ge, F.
    Chen, X-J
    Tang, C.
    Ma, J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (12) : 5242 - 5250
12345